What is the impact of local control in Ewing sarcoma: analysis of the first Brazilian collaborative study group-EWING1

Detalhes bibliográficos
Autor(a) principal: Becker, Ricardo G.
Data de Publicação: 2017
Outros Autores: Gregianin, Lauro J., Galia, Carlos R., Jesus-Garcia Filho, Reynaldo [UNIFESP], Toller, Eduardo A., Badell, Gerardo, Nakagawa, Suely A., David, Alexandre, Baptista, Andre M., Yonamime, Eduardo S., Serafini, Osvaldo A., Penna, Valter, Santos, Julie Francine C., Brunetto, Algemir L.
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Repositório Institucional da UNIFESP
Texto Completo: http://dx.doi.org/10.1186/s12885-017-3391-5
https://repositorio.unifesp.br/handle/11600/53653
Resumo: Background: Relapse in localized Ewing sarcoma patients has been a matter of concern regarding poor prognosis. Therefore, we investigated the impact of local control modality (surgery, surgery plus radiotherapy, and radiotherapy) on clinical outcomes such as survival and recurrence in patients with non-metastatic Ewing sarcoma treated on the first Brazilian Collaborative Group Trial of the Ewing Family of Tumors (EWING1). Methods: Seventy-three patients with localized Ewing sarcoma of bone aged < 30 years were included. The treating physicians defined the modality of local control based on the recommendations of the coordinating center and the patient and tumor characteristics. Possible associations of local control modality with local failure (LF), disease-free survival (DFS), event-free survival (EFS), overall survival (OS), and clinical characteristics were analyzed. Results: Mean patient age was 12.8 years (range, 2 to 25 years) and median follow-up time was 4.5 years (range, 2. 3 to 6.7 years). Forty-seven patients underwent surgery, 13 received radiotherapy, and 13 received both. The 5-year EFS, OS, and DFS for all patients was 62.1%, 63.3%, and 73.1%, respectively. The 5-year cumulative incidence (CI) of LF was 7.6% for surgery, 11.1% for radiotherapy, and 0% for postoperative radiotherapy (PORT) (p = 0.61). The 5-year EFS was 71.7% for surgery, 30.8% for radiotherapy, and 64.1% for PORT (p = 0.009). Conclusions: There was a significant effect of local control modality on EFS and OS in the study. Surgery and PORT modalities yielded very close results. The group treated with radiotherapy alone had considerably worse outcomes. This may be confounded by greater risk factors in these patients. There was no significant effect of local control modality on the CI of LF and DFS.
id UFSP_2958ba21258c4c874f1d77332f85566e
oai_identifier_str oai:repositorio.unifesp.br:11600/53653
network_acronym_str UFSP
network_name_str Repositório Institucional da UNIFESP
repository_id_str 3465
spelling Becker, Ricardo G.Gregianin, Lauro J.Galia, Carlos R.Jesus-Garcia Filho, Reynaldo [UNIFESP]Toller, Eduardo A.Badell, GerardoNakagawa, Suely A.David, AlexandreBaptista, Andre M.Yonamime, Eduardo S.Serafini, Osvaldo A.Penna, ValterSantos, Julie Francine C.Brunetto, Algemir L.2020-06-26T16:30:36Z2020-06-26T16:30:36Z2017http://dx.doi.org/10.1186/s12885-017-3391-5Bmc Cancer. London, v. 17, p. -, 2017.1471-2407https://repositorio.unifesp.br/handle/11600/53653WOS000403379500006.pdf10.1186/s12885-017-3391-5WOS:000403379500006Background: Relapse in localized Ewing sarcoma patients has been a matter of concern regarding poor prognosis. Therefore, we investigated the impact of local control modality (surgery, surgery plus radiotherapy, and radiotherapy) on clinical outcomes such as survival and recurrence in patients with non-metastatic Ewing sarcoma treated on the first Brazilian Collaborative Group Trial of the Ewing Family of Tumors (EWING1). Methods: Seventy-three patients with localized Ewing sarcoma of bone aged < 30 years were included. The treating physicians defined the modality of local control based on the recommendations of the coordinating center and the patient and tumor characteristics. Possible associations of local control modality with local failure (LF), disease-free survival (DFS), event-free survival (EFS), overall survival (OS), and clinical characteristics were analyzed. Results: Mean patient age was 12.8 years (range, 2 to 25 years) and median follow-up time was 4.5 years (range, 2. 3 to 6.7 years). Forty-seven patients underwent surgery, 13 received radiotherapy, and 13 received both. The 5-year EFS, OS, and DFS for all patients was 62.1%, 63.3%, and 73.1%, respectively. The 5-year cumulative incidence (CI) of LF was 7.6% for surgery, 11.1% for radiotherapy, and 0% for postoperative radiotherapy (PORT) (p = 0.61). The 5-year EFS was 71.7% for surgery, 30.8% for radiotherapy, and 64.1% for PORT (p = 0.009). Conclusions: There was a significant effect of local control modality on EFS and OS in the study. Surgery and PORT modalities yielded very close results. The group treated with radiotherapy alone had considerably worse outcomes. This may be confounded by greater risk factors in these patients. There was no significant effect of local control modality on the CI of LF and DFS.Children's Cancer InstituteRafael Accordi Foundation, Porto Alegre, RS, BrazilHCPA, Serv Orthoped & Traumatol, Rua Ramiro Barcelos 2350, BR-90035903 Porto Alegre, RS, BrazilUniv Fed Rio Grande do Sul, HCPA, Dept Pediat, Porto Alegre, RS, BrazilPontificia Univ Catolica Rio Grande Sul PUCRS, Dept Pediat, Hosp Sao Lucas, Porto Alegre, RS, BrazilHCPA, Serv Orthoped & Traumatol, Porto Alegre, RS, BrazilUniv Fed Sao Paulo UNIFESP, Support Grp Children & Adolescents Canc GRAACC, Sao Paulo, SP, BrazilHosp Canc Infantojuvenil, Fundacao Pio 12, Barretos, SP, BrazilCtr Hosp Pereira Rossell, Montevideo, UruguayHosp AC Camargo Canc Ctr, Orthoped Serv, Sao Paulo, SP, BrazilSanta Casa Misericordia Porto Alegre, Serv Orthoped & Traumatol, Porto Alegre, RS, BrazilUniv Sao Paulo, Orthoped Trauma Inst, Hosp Clin Sao Paulo, Sch Med, Sao Paulo, SP, BrazilSanta Casa Misericordia Sao Paulo HSCSP, Dept Orthoped & Traumatol, Sao Paulo, SP, BrazilPontificia Univ Catolica Rio Grande Sul PUCRS, Hosp Sao Lucas, Serv Orthoped & Traumatol, Porto Alegre, RS, BrazilUniv Estadual Paulista UNESP, Hosp Clin Botucatu, Sch Med, Botucatu, SP, BrazilInst Canc Infantil, Porto Alegre, RS, BrazilUniv Fed Sao Paulo UNIFESP, Support Grp Children & Adolescents Canc GRAACC, Sao Paulo, SP, BrazilChildren's Cancer InstituteRafael Accordi Foundation, Porto Alegre, RS, BrazilWeb of Science-engBiomed Central LtdBmc CancerEwing sarcomaLocal controlRadiation oncologySurgeryBone tumorsOrthopedicsWhat is the impact of local control in Ewing sarcoma: analysis of the first Brazilian collaborative study group-EWING1info:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleLondon17info:eu-repo/semantics/openAccessreponame:Repositório Institucional da UNIFESPinstname:Universidade Federal de São Paulo (UNIFESP)instacron:UNIFESPORIGINALWOS000403379500006.pdfapplication/pdf557601${dspace.ui.url}/bitstream/11600/53653/1/WOS000403379500006.pdfec24d70f5874d52569293e448c7b3e82MD51open accessTEXTWOS000403379500006.pdf.txtWOS000403379500006.pdf.txtExtracted texttext/plain36654${dspace.ui.url}/bitstream/11600/53653/2/WOS000403379500006.pdf.txt3d95be1b4fc2c2abef892d92a5cacd46MD52open accessTHUMBNAILWOS000403379500006.pdf.jpgWOS000403379500006.pdf.jpgIM Thumbnailimage/jpeg6371${dspace.ui.url}/bitstream/11600/53653/4/WOS000403379500006.pdf.jpgbbc1213aef7b07aa69d8d8e47ab41025MD54open access11600/536532022-08-01 09:48:16.938open accessoai:repositorio.unifesp.br:11600/53653Repositório InstitucionalPUBhttp://www.repositorio.unifesp.br/oai/requestopendoar:34652023-05-25T12:20:18.109022Repositório Institucional da UNIFESP - Universidade Federal de São Paulo (UNIFESP)false
dc.title.en.fl_str_mv What is the impact of local control in Ewing sarcoma: analysis of the first Brazilian collaborative study group-EWING1
title What is the impact of local control in Ewing sarcoma: analysis of the first Brazilian collaborative study group-EWING1
spellingShingle What is the impact of local control in Ewing sarcoma: analysis of the first Brazilian collaborative study group-EWING1
Becker, Ricardo G.
Ewing sarcoma
Local control
Radiation oncology
Surgery
Bone tumors
Orthopedics
title_short What is the impact of local control in Ewing sarcoma: analysis of the first Brazilian collaborative study group-EWING1
title_full What is the impact of local control in Ewing sarcoma: analysis of the first Brazilian collaborative study group-EWING1
title_fullStr What is the impact of local control in Ewing sarcoma: analysis of the first Brazilian collaborative study group-EWING1
title_full_unstemmed What is the impact of local control in Ewing sarcoma: analysis of the first Brazilian collaborative study group-EWING1
title_sort What is the impact of local control in Ewing sarcoma: analysis of the first Brazilian collaborative study group-EWING1
author Becker, Ricardo G.
author_facet Becker, Ricardo G.
Gregianin, Lauro J.
Galia, Carlos R.
Jesus-Garcia Filho, Reynaldo [UNIFESP]
Toller, Eduardo A.
Badell, Gerardo
Nakagawa, Suely A.
David, Alexandre
Baptista, Andre M.
Yonamime, Eduardo S.
Serafini, Osvaldo A.
Penna, Valter
Santos, Julie Francine C.
Brunetto, Algemir L.
author_role author
author2 Gregianin, Lauro J.
Galia, Carlos R.
Jesus-Garcia Filho, Reynaldo [UNIFESP]
Toller, Eduardo A.
Badell, Gerardo
Nakagawa, Suely A.
David, Alexandre
Baptista, Andre M.
Yonamime, Eduardo S.
Serafini, Osvaldo A.
Penna, Valter
Santos, Julie Francine C.
Brunetto, Algemir L.
author2_role author
author
author
author
author
author
author
author
author
author
author
author
author
dc.contributor.author.fl_str_mv Becker, Ricardo G.
Gregianin, Lauro J.
Galia, Carlos R.
Jesus-Garcia Filho, Reynaldo [UNIFESP]
Toller, Eduardo A.
Badell, Gerardo
Nakagawa, Suely A.
David, Alexandre
Baptista, Andre M.
Yonamime, Eduardo S.
Serafini, Osvaldo A.
Penna, Valter
Santos, Julie Francine C.
Brunetto, Algemir L.
dc.subject.eng.fl_str_mv Ewing sarcoma
Local control
Radiation oncology
Surgery
Bone tumors
Orthopedics
topic Ewing sarcoma
Local control
Radiation oncology
Surgery
Bone tumors
Orthopedics
description Background: Relapse in localized Ewing sarcoma patients has been a matter of concern regarding poor prognosis. Therefore, we investigated the impact of local control modality (surgery, surgery plus radiotherapy, and radiotherapy) on clinical outcomes such as survival and recurrence in patients with non-metastatic Ewing sarcoma treated on the first Brazilian Collaborative Group Trial of the Ewing Family of Tumors (EWING1). Methods: Seventy-three patients with localized Ewing sarcoma of bone aged < 30 years were included. The treating physicians defined the modality of local control based on the recommendations of the coordinating center and the patient and tumor characteristics. Possible associations of local control modality with local failure (LF), disease-free survival (DFS), event-free survival (EFS), overall survival (OS), and clinical characteristics were analyzed. Results: Mean patient age was 12.8 years (range, 2 to 25 years) and median follow-up time was 4.5 years (range, 2. 3 to 6.7 years). Forty-seven patients underwent surgery, 13 received radiotherapy, and 13 received both. The 5-year EFS, OS, and DFS for all patients was 62.1%, 63.3%, and 73.1%, respectively. The 5-year cumulative incidence (CI) of LF was 7.6% for surgery, 11.1% for radiotherapy, and 0% for postoperative radiotherapy (PORT) (p = 0.61). The 5-year EFS was 71.7% for surgery, 30.8% for radiotherapy, and 64.1% for PORT (p = 0.009). Conclusions: There was a significant effect of local control modality on EFS and OS in the study. Surgery and PORT modalities yielded very close results. The group treated with radiotherapy alone had considerably worse outcomes. This may be confounded by greater risk factors in these patients. There was no significant effect of local control modality on the CI of LF and DFS.
publishDate 2017
dc.date.issued.fl_str_mv 2017
dc.date.accessioned.fl_str_mv 2020-06-26T16:30:36Z
dc.date.available.fl_str_mv 2020-06-26T16:30:36Z
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
format article
status_str publishedVersion
dc.identifier.].fl_str_mv http://dx.doi.org/10.1186/s12885-017-3391-5
dc.identifier.citation.fl_str_mv Bmc Cancer. London, v. 17, p. -, 2017.
dc.identifier.uri.fl_str_mv https://repositorio.unifesp.br/handle/11600/53653
dc.identifier.issn.none.fl_str_mv 1471-2407
dc.identifier.file.none.fl_str_mv WOS000403379500006.pdf
dc.identifier.doi.none.fl_str_mv 10.1186/s12885-017-3391-5
dc.identifier.wos.none.fl_str_mv WOS:000403379500006
url http://dx.doi.org/10.1186/s12885-017-3391-5
https://repositorio.unifesp.br/handle/11600/53653
identifier_str_mv Bmc Cancer. London, v. 17, p. -, 2017.
1471-2407
WOS000403379500006.pdf
10.1186/s12885-017-3391-5
WOS:000403379500006
dc.language.iso.fl_str_mv eng
language eng
dc.relation.ispartof.none.fl_str_mv Bmc Cancer
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv -
dc.coverage.none.fl_str_mv London
dc.publisher.none.fl_str_mv Biomed Central Ltd
publisher.none.fl_str_mv Biomed Central Ltd
dc.source.none.fl_str_mv reponame:Repositório Institucional da UNIFESP
instname:Universidade Federal de São Paulo (UNIFESP)
instacron:UNIFESP
instname_str Universidade Federal de São Paulo (UNIFESP)
instacron_str UNIFESP
institution UNIFESP
reponame_str Repositório Institucional da UNIFESP
collection Repositório Institucional da UNIFESP
bitstream.url.fl_str_mv ${dspace.ui.url}/bitstream/11600/53653/1/WOS000403379500006.pdf
${dspace.ui.url}/bitstream/11600/53653/2/WOS000403379500006.pdf.txt
${dspace.ui.url}/bitstream/11600/53653/4/WOS000403379500006.pdf.jpg
bitstream.checksum.fl_str_mv ec24d70f5874d52569293e448c7b3e82
3d95be1b4fc2c2abef892d92a5cacd46
bbc1213aef7b07aa69d8d8e47ab41025
bitstream.checksumAlgorithm.fl_str_mv MD5
MD5
MD5
repository.name.fl_str_mv Repositório Institucional da UNIFESP - Universidade Federal de São Paulo (UNIFESP)
repository.mail.fl_str_mv
_version_ 1783460278152724480